A randomized single-blind pilot study of compensatory strategies in schizophrenia outpatients

被引:68
作者
Velligan, DI
Prihoda, TJ
Ritch, JL
Maples, N
Bow-Thomas, CC
Dassori, A
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Psychiat, Div Schizophrenia & Related Disorders, San Antonio, TX 78229 USA
[2] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[3] Univ Texas, Hlth Sci Ctr, Dept Psychiat & Pathol, San Antonio, TX 78285 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX 78284 USA
[5] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[6] Univ Texas, Hlth Sci Ctr, Dept Psychiat, San Antonio, TX USA
[7] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[8] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
[9] Univ Texas, Hlth Sci Ctr, Dept Psychiat, Div Schizophrenia & Related Disorders, San Antonio, TX 78229 USA
[10] San Antonio State Hosp, Clin Res Unit, San Antonio, TX USA
关键词
schizophrenia; cognitive deficits; compensatory strategies; environmental supports; psychosocial treatment;
D O I
10.1093/oxfordjournals.schbul.a006938
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In a previous study, we found that cognitive adaptation training (CAT)-a manual-driven program of environmental supports designed to bypass cognitive deficits-improved multiple domains of outcome in schizophrenia patients recently discharged from a State psychiatric facility. The present study examined the efficacy of CAT in a sample of patients who had been in the community at least 3 months. Forty-five medicated schizophrenia patients were randomly assigned for 9 months to one of three conditions: (1) CAT, (2) a condition that controlled for therapist time and provided environmental changes unrelated to cognitive deficits, or (3) followup only. Comprehensive assessments were conducted every 3 months by blinded raters. Results of repeated measures analyses of covariance for mixed models indicated that patients participating in CAT had better adaptive function and quality of life, and fewer positive symptoms than those in the two non-CAT conditions. Results indicate that compensatory strategies may improve various outcomes in schizophrenia outpatients.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 50 条
  • [21] Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial
    Sacchetti, E
    Panariello, A
    Regini, C
    Valsecchi, P
    SCHIZOPHRENIA RESEARCH, 2004, 69 (2-3) : 325 - 331
  • [22] Effects of a symptom management program on auditory hallucinations in Thai outpatients with a diagnosis of schizophrenia: A pilot study
    Kanungpairn, Thidarat
    Sitthimongkol, Yajai
    Wattanapailin, Atirat
    NURSING & HEALTH SCIENCES, 2007, 9 (01) : 32 - 37
  • [23] A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder
    Talaei, Ali
    Hosseini, Farhad Farid
    Aghili, Zahra
    Akhondzadeh, Shahin
    Asadpour, Elham
    Mehramiz, Neema John
    Forouzanfar, Fatemeh
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (04) : 236 - 242
  • [24] Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: Eight-week randomized, single-blind, placebo-controlled, multicenter study
    Lee, Moon-Soo
    Song, Hyun-Cheol
    An, Hyonggin
    Yang, Jaewon
    Ko, Young-Hoon
    Jung, In-Kwa
    Joe, Sook-Haeng
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 64 (01) : 19 - 27
  • [25] Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders
    Cohen, Elan A.
    Hassman, Howard H.
    Ereshefsky, Larry
    Walling, David P.
    Grindell, Vera M.
    Keefe, Richard S. E.
    Wyka, Katarzyna
    Horan, William P.
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (04) : 844 - 850
  • [26] Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
    Woo, Young Sup
    Park, Sung-Yong
    Yoon, Bo-Hyun
    Choi, Won-Seok
    Wang, Sheng-Min
    Bahk, Won-Myong
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (03) : 567 - 572
  • [27] A Double-Blind, Randomized Comparative Study of Aripiprazole and Olanzapine in Patients with Schizophrenia
    Fleischhacker, W. Wolfgang
    McQuade, Robert D.
    Marcus, Ronald N.
    Archibald, Donald
    Swanink, Rene
    Carson, William H.
    BIOLOGICAL PSYCHIATRY, 2009, 65 (06) : 510 - 517
  • [28] α-Lipoic Acid as Adjunctive Treatment for Schizophrenia A Randomized Double-Blind Study
    De Lima, David Nunes
    Costa Filho, Carlos Winston Luz
    Frota, Ilgner Justa
    de Oliveira, Alissandra Lima Barbosa
    de Souza Menezes, Carlos Eduardo
    Chaves Filho, Adriano Jose Maia
    de Almeida Viana, Glautemberg
    de Moura Campos, Eugenio
    Collares, Monica
    de Queiroz, Maria Goretti Rodrigues
    da Cruz Fonseca, Said Goncalvez
    Vasconcelos, Silvania Maria Mendes
    Macedo, Danielle S.
    Sanders, Lia Lira Olivier
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2023, 43 (01) : 39 - 45
  • [29] Resting Frontal EEG Asymmetry and Shyness and Sociability in Schizophrenia: A Pilot Study of Community-Based Outpatients
    Jetha, Michelle K.
    Schmidt, Louis A.
    Goldberg, Joel O.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2009, 119 (06) : 847 - 856
  • [30] Effects of Music Therapy on Drug Therapy of Adult Psychiatric Outpatients: A Pilot Randomized Controlled Study
    Degli Stefani, Mario
    Biasutti, Michele
    FRONTIERS IN PSYCHOLOGY, 2016, 7